Evidence map›Paper›PMID 27396331›Full record

ArticleCell reports2016

GFRA2 Identifies Cardiac Progenitors and Mediates Cardiomyocyte Differentiation in a RET-Independent Signaling Pathway.

Hidekazu Ishida, Rie Saba, Ioannis Kokkinopoulos, Masakazu Hashimoto, Osamu Yamaguchi, Sonja Nowotschin, Manabu Shiraishi, Prashant Ruchaya, Duncan Miller, Stephen Harmer and 11 more

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in Cell reports, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
3.1field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 35 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Review
  18. Ajmaline blocks IStem cell research · 2017
    Article
  19. Are we closer to cardiac regeneration?Stem cell investigation · 2016
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

21 authors at 4 institutions in 3 countries.

Hidekazu IshidaCentre for Endocrinology, William Harvey Research Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London EC1M 6BQ, UK; Translational Medicine and Therapeutics, William Harvey Research Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London EC1M 6BQ, UK; Department of Paediatrics, Osaka University Graduate School of Medicine, Osaka 565-0871, Japan.
Rie SabaCentre for Endocrinology, William Harvey Research Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London EC1M 6BQ, UK; Translational Medicine and Therapeutics, William Harvey Research Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London EC1M 6BQ, UK.
Ioannis KokkinopoulosCentre for Endocrinology, William Harvey Research Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London EC1M 6BQ, UK; Translational Medicine and Therapeutics, William Harvey Research Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London EC1M 6BQ, UK.
Masakazu HashimotoLaboratory for Embryogenesis, Osaka University Graduate School of Frontier Biosciences, Osaka 565-0871, Japan.
Osamu YamaguchiDepartment of Cardiovascular Medicine, Osaka University Graduate School of Medicine, Osaka 565-0871, Japan.
Sonja NowotschinDevelopmental Biology Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
Manabu ShiraishiTranslational Medicine and Therapeutics, William Harvey Research Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London EC1M 6BQ, UK.
Prashant RuchayaTranslational Medicine and Therapeutics, William Harvey Research Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London EC1M 6BQ, UK; Centre of Human and Aerospace Physiological Sciences, School of Biomedical Sciences, King's College, London, SE1 1UL, UK.
Duncan MillerCardiac Electrophysiology, William Harvey Research Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London EC1M 6BQ, UK.
Stephen HarmerCardiac Electrophysiology, William Harvey Research Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London EC1M 6BQ, UK.
Ariel PoliandriCentre for Endocrinology, William Harvey Research Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London EC1M 6BQ, UK.
Shigetoyo KogakiDepartment of Paediatrics, Osaka University Graduate School of Medicine, Osaka 565-0871, Japan.
Yasushi SakataDepartment of Cardiovascular Medicine, Osaka University Graduate School of Medicine, Osaka 565-0871, Japan.
Leo DunkelCentre for Endocrinology, William Harvey Research Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London EC1M 6BQ, UK.
Andrew TinkerCardiac Electrophysiology, William Harvey Research Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London EC1M 6BQ, UK.
Anna-Katerina HadjantonakisDevelopmental Biology Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
Yoshiki SawaDepartment of Cardiovascular Surgery, Osaka University Graduate School of Medicine, Osaka 565-0871, Japan.
Hiroshi SasakiLaboratory for Embryogenesis, Osaka University Graduate School of Frontier Biosciences, Osaka 565-0871, Japan.
Keiichi OzonoDepartment of Paediatrics, Osaka University Graduate School of Medicine, Osaka 565-0871, Japan.
Ken SuzukiTranslational Medicine and Therapeutics, William Harvey Research Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London EC1M 6BQ, UK.
Kenta YashiroCentre for Endocrinology, William Harvey Research Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London EC1M 6BQ, UK; Translational Medicine and Therapeutics, William Harvey Research Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London EC1M 6BQ, UK. Electronic address: drkyashiro@gmail.com.
Osaka University · JPWilliam Harvey Research Institute · GBQueen Mary University of London · GBMemorial Sloan Kettering Cancer Center · US

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Nicholas D Socci · 1985 to 2026
$347.4M
Morphogenesis of the paraxial mesoderm in miceR01HD052115 · NICHD · SLOAN-KETTERING INST CAN RESEARCH · PI HADJANTONAKIS, ANNA-KATERINA · 2006 to 2015
$4.1M
Morphogenesis of mammalian gut endodermR01DK084391 · NIDDK · SLOAN-KETTERING INST CAN RESEARCH · PI HADJANTONAKIS, ANNA-KATERINA · 2009 to 2018
$4.1M
British Heart Foundation FS/12/21/29482British Heart Foundation RG/15/15/31742British Heart Foundation RG/15/3/31236British Heart Foundation SP/15/9/31605Medical Research Council G0900105Medical Research Council MR/J007625/1NCI NIH HHS P30 CA008748NICHD NIH HHS R01 HD052115NIDDK NIH HHS R01 DK084391
6 · The paper itself

Abstract

A surface marker that distinctly identifies cardiac progenitors (CPs) is essential for the robust isolation of these cells, circumventing the necessity of genetic modification. Here, we demonstrate that a Glycosylphosphatidylinositol-anchor containing neurotrophic factor receptor, Glial cell line-derived neurotrophic factor receptor alpha 2 (Gfra2), specifically marks CPs. GFRA2 expression facilitates the isolation of CPs by fluorescence activated cell sorting from differentiating mouse and human pluripotent stem cells. Gfra2 mutants reveal an important role for GFRA2 in cardiomyocyte differentiation and development both in vitro and in vivo. Mechanistically, the cardiac GFRA2 signaling pathway is distinct from the canonical pathway dependent on the RET tyrosine kinase and its established ligands. Collectively, our findings establish a platform for investigating the biology of CPs as a foundation for future development of CP transplantation for treating heart failure.

Indexed as

AnimalsCell DifferentiationCells, CulturedGlial Cell Line-Derived Neurotrophic Factor ReceptorsGlycosylphosphatidylinositolsHumansLigandsMiceMyocytes, CardiacOrganogenesisPluripotent Stem CellsProto-Oncogene Proteins c-retReceptor Protein-Tyrosine KinasesSignal TransductionGFRA2 protein, humanGfra2 protein, mouseGlial Cell Line-Derived Neurotrophic Factor ReceptorsGlycosylphosphatidylinositolsLigandsProto-Oncogene Proteins c-retReceptor Protein-Tyrosine KinasesRET protein, humanRet protein, mouse

Identifiers

PMID27396331
PMCPMC4967477
OpenAlexW2467309773

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.